BlackRock Capital Allocation Term Trust (NYSE:BCAT) Sets New 1-Year High – Here’s What Happened

BlackRock Capital Allocation Term Trust (NYSE:BCAT) shares hit a new 52-week high on Tuesday . The company traded as high as $15.71 and last traded at $15.5950, with a volume of 765581 shares changing hands. The stock had previously closed at $15.52.

BlackRock Capital Allocation Term Trust Price Performance

The stock’s fifty day moving average price is $14.84 and its two-hundred day moving average price is $14.65.

BlackRock Capital Allocation Term Trust Dividend Announcement

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th will be issued a $0.2579 dividend. This represents a c) dividend on an annualized basis and a dividend yield of 19.7%. The ex-dividend date is Monday, June 15th.

Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust

A number of hedge funds and other institutional investors have recently modified their holdings of BCAT. Keener Financial Planning LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at $29,000. Geneos Wealth Management Inc. raised its holdings in shares of BlackRock Capital Allocation Term Trust by 341.7% in the 2nd quarter. Geneos Wealth Management Inc. now owns 2,045 shares of the company’s stock valued at $31,000 after purchasing an additional 1,582 shares in the last quarter. N.E.W. Advisory Services LLC raised its holdings in shares of BlackRock Capital Allocation Term Trust by 100.0% in the 4th quarter. N.E.W. Advisory Services LLC now owns 2,400 shares of the company’s stock valued at $34,000 after purchasing an additional 1,200 shares in the last quarter. Parallel Advisors LLC acquired a new stake in shares of BlackRock Capital Allocation Term Trust in the 3rd quarter valued at $47,000. Finally, Brown Brothers Harriman & Co. grew its position in shares of BlackRock Capital Allocation Term Trust by 450.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 5,500 shares of the company’s stock valued at $81,000 after buying an additional 4,500 shares during the last quarter. 36.12% of the stock is currently owned by institutional investors and hedge funds.

About BlackRock Capital Allocation Term Trust

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.